Pieper Steven

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pieper Steven's trades of Xeris Biopharma Holdings, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-01
PlS Planned sale
34,621 +16.8%
358.36
US$4,613,245 		34,621 +16.8% 358.36 US$4,613,245
2026-09-01 2026-09-01
PlS Planned sale
78,291 +0.8%
357.71
US$3,837,370 		78,291 +0.8% 357.71 US$3,837,370
2026-08-12 2026-08-12
PlS Planned sale
65,892 -0.7%
407.51
US$2,539,895 		65,892 -0.7% 407.51 US$2,539,895
2026-08-12 2026-08-12
PrS Proposed sale
20,000
8.39
US$167,800 		20,000 8.39 US$167,800
2026-07-07 2026-07-07
PlS Planned sale
27,600 -2.0%
8.52
US$235,276 		27,600 -2.0% 8.52 US$235,276
2026-07-07 2026-07-07
PrS Proposed sale
27,600
8.37
US$231,012 		27,600 8.37 US$231,012
2026-07-07 2026-07-06
PlS Planned sale
17,400 -1.2%
8.50
US$147,900 		17,400 -1.2% 8.50 US$147,900
2026-07-06 2026-07-06
PrS Proposed sale
17,400
8.28
US$144,072 		17,400 8.28 US$144,072
2023-11-21 2023-11-20
B Purchase
28,000 +2.4%
1.95
US$54,600 		28,000 +2.4% 1.95 US$54,600
2021-11-12 2021-11-10
B Purchase
25,000 +15.8%
2.00
US$49,918 		25,000 +15.8% 2.00 US$49,918